Year |
Citation |
Score |
2023 |
Palakurthi B, Fross SR, Guldner IH, Aleksandrovic E, Liu X, Martino AK, Wang Q, Neff RA, Golomb SM, Lewis C, Peng Y, Howe EN, Zhang S. Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer. Nature Communications. 14: 2109. PMID 37055410 DOI: 10.1038/s41467-023-37727-y |
0.513 |
|
2021 |
Guldner IH, Golomb SM, Wang Q, Wang E, Zhang S. Isolation of mouse brain-infiltrating leukocytes for single cell profiling of epitopes and transcriptomes. Star Protocols. 2: 100537. PMID 34036283 DOI: 10.1016/j.xpro.2021.100537 |
0.768 |
|
2020 |
Golomb SM, Guldner IH, Zhao A, Wang Q, Palakurthi B, Aleksandrovic EA, Lopez JA, Lee SW, Yang K, Zhang S. Multi-modal Single-Cell Analysis Reveals Brain Immune Landscape Plasticity during Aging and Gut Microbiota Dysbiosis. Cell Reports. 33: 108438. PMID 33264626 DOI: 10.1016/j.celrep.2020.108438 |
0.619 |
|
2020 |
Guldner IH, Wang Q, Yang L, Golomb SM, Zhao Z, Lopez JA, Brunory A, Howe EN, Zhang Y, Palakurthi B, Barron M, Gao H, Xuei X, Liu Y, Li J, et al. CNS-Native Myeloid Cells Drive Immune Suppression in the Brain Metastatic Niche through Cxcl10. Cell. PMID 33113353 DOI: 10.1016/j.cell.2020.09.064 |
0.705 |
|
2019 |
Wang Q, Guldner IH, Golomb SM, Sun L, Harris JA, Lu X, Zhang S. Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancer. Nature Communications. 10: 3817. PMID 31444334 DOI: 10.1038/S41467-019-11729-1 |
0.792 |
|
Show low-probability matches. |